Get started
ROSSARI BIOTECH LTDROSSARI BIOTECH LTDROSSARI BIOTECH LTD

ROSSARI BIOTECH LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

ROSSARI trade ideas

ROSSARI BIOTECH Showing Change in Price StructureNSE:ROSSARI .................................................................................................................... .................................................................................................................... .................................................................................................................... Update on the expansion projects at Dahej Facilities .................................................................................................................... • In the Q2FY24 the Company had announced an expansion of its facility at Dahej by adding up 20,000 MTPA capacity for products related to HPPC in the specialty chemical space, as well as for producing ingredients for its subsidiary companies. Also, to cater to the growing demand in agro chemicals, home and personal care, oil & gas and the pharma sector, the Company had further announced expansion of the Ethoxylation capacity by 30,000 MTPA at the Dahej facility of Unitop Chemicals Private Limited. • Work on both these projects are progressing as planned. Commissioning is expected to happen, in a phased manner in the current year .................................................................................................................... .................................................................................................................... .................................................................................................................... • Consistent growth trajectory over the past three years, driven by both organic and inorganic growth strategies • While near-term investments and strategic initiatives have led to a moderation in ROCE and ROE, the balance sheet position remains strong. The Company is confident of reporting improved return metrics in the future as these investments start yielding results
NSE:ROSSARILong
by iism-ExpertTrading
Rossari Biotech Steady Financial Growth with Strong Market PosRossari Biotech has demonstrated consistent financial growth, with its revenue increasing from ₹516 crores in FY2019 to ₹1,910 crores in the trailing twelve months (TTM) of FY2024. The company has maintained a stable operating profit margin around 13-17% over the years, reflecting its efficient cost management and strong market position. Although the return on equity (ROE) has slightly decreased to 13% in the most recent fiscal year, it remains a solid performer within the specialty chemicals sector. Additionally, Rossari's conservative dividend payout and strategic reinvestment into the business indicate a focus on long-term growth. I am buying at 900-915 zone with a stop loss at 790 for a target of 1250-1600+ Disclaimer: The information provided here is intended for informational purposes only and should not be construed as investment advice or a recommendation to buy or sell any securities. The opinions expressed are those of the author and are subject to change without notice. Past performance is not indicative of future results. Investors should consult their financial advisors before making any investment decisions. Trading and investing in financial markets involve risks, including the loss of principal. Neither the author nor any of their affiliates shall be held liable for any loss or damage resulting from the use of this information.
NSE:ROSSARILong
by profitoptionnew
ROSSARI - Bullish SetupStock name - Rossari Biotech Limited. Weekly chart setup Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Master Score - B Disclaimer: This is for demonstration and educational purpose only. this is not buying and selling recommendations. I am not SEBI registered. please consult your financial advisor before taking any trade.
NSE:ROSSARILong
by tanwartarun50
SWING IDEA - ROSSARI BIOTECHConsider a compelling swing trade opportunity in Rossari Biotech , a leading specialty chemicals manufacturer in India, renowned for its innovative and sustainable solutions across various industries. Reasons are listed below : Price at Support Zone : Rossari Biotech is trading at its support zone, where it was initially listed, indicating potential buying interest and stability at these levels. Doji Candle Formation : A doji candlestick pattern has formed, confirming the bullish momentum indicated by the preceding marubozu candle. This suggests that the price is holding onto higher levels and may continue to move upward. 0.618 Fibonacci Support : Finding support at the 0.618 Fibonacci level strengthens the bullish case, providing a solid foundation for potential upward movement. Initiation of Double Bottom Pattern : The beginning of the formation of a double bottom pattern suggests a potential trend reversal and bullish continuation, indicating a shift in market sentiment. Increase in Volumes : An increase in trading volumes reflects growing market interest and potential accumulation by investors, adding confirmation to the bullish thesis for Rossari Biotech. Target - 809 // 890 StopLoss - weekly close below 655 DISCLAIMER - Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services. @visionary.growth.insights
NSE:ROSSARILong
by Visionary_Growth_Insights
Rossari Biotech LtdTarget given in the chart SL 690 FUNDAMENTALS Market Cap ₹ 4,710 Cr. Current Price ₹ 852 High / Low ₹ 904 / 657 Stock P/E 36.0 Book Value ₹ 190 Dividend Yield 0.06 % ROCE 18.3 % ROE 13.3 % Face Value ₹ 2.00 Price to book value 4.51 Intrinsic Value ₹ 590 PEG Ratio 1.55 Price to Sales 2.57 Debt ₹ 119 Cr. Debt to equity 0.11 Int Coverage 10.2 Reserves ₹ 1,037 Cr. Promoter holding 68.3 % Pledged percentage 0.00 % EPS last year ₹ 23.7 Net CF ₹ -43.8 Cr. Price to Cash Flow 109 Free Cash Flow ₹ -82.5 Cr. OPM last year 13.6 % Return on assets 8.90 % Sales growth 10.6 %
NSE:ROSSARILong
by madhu2811
Rossari Biotech LTD Trend AnalysisPrice bounced at key support level and RSI showing moderate bullish divergence on daily TF. Expecting the price to make a leading diagonal pattern as highlighted, will update the chart later if any changes observed. Good to buy at CMP for the following targets: Medium term swing target @ 1270 (80% ROI) Long term positional target @ 1560 (120% ROI) Strong fundamentals with highest ever Sales & Net Profit. Do your own due diligence before taking any action. Peace!!
NSE:ROSSARILong
by Swastik24